CG Oncology Inc. Common s... (CGON)

NASDAQ: CGON · Real-Time Price · USD

27.76

0.82 (3.04%)

At close: May 01, 2025, 3:59 PM

27.73

-0.11%

Pre-market: May 02, 2025, 05:15 AM EDT

CG Oncology Common stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-88.04M	-48.61M	-35.44M	-12.84M
Depreciation & Amortization	32K	17K	15K	10K
Stock-Based Compensation	11.4M	1.53M	676K	1.11M
Other Working Capital	n/a	1.43M	4.46M	-2.54M
Other Non-Cash Items	-2.11M	-2.06M	1.23M	584K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	3.44M	4.44M	-1.97M
Operating Cash Flow	-78.71M	-45.68M	-29.8M	-13.65M
Capital Expenditures	-234K	n/a	-14K	-97K
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-1.05B	-517.61M	-55.34M	n/a
Sales Maturities Of Investments	745.41M	396.42M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-55.34M	n/a
Investing Cash Flow	-300.76M	-121.19M	-55.35M	-97K
Debt Repayment	-365K	-16.29M	n/a	15.2M
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-825K	n/a	n/a	n/a
Financial Cash Flow	628.28M	87M	119.69M	15.45M
Net Cash Flow	248.8M	-79.88M	34.54M	1.7M
Free Cash Flow	-78.95M	-45.68M	-29.82M	-13.75M